Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 vistas
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios